Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionglucuronosyltransferase activity

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

2.39e-0935325GO:0015020
GeneOntologyMolecularFunctionUDP-glycosyltransferase activity

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

4.22e-06153325GO:0008194
GeneOntologyMolecularFunctionhexosyltransferase activity

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

2.01e-05211325GO:0016758
GeneOntologyMolecularFunctionglycosyltransferase activity

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

8.82e-05288325GO:0016757
GeneOntologyMolecularFunctionphosphatidylserine 1-acylhydrolase activity

PLA2G15 LIPG

1.63e-0412322GO:0052739
GeneOntologyMolecularFunctionphospholipase A1 activity

PLA2G15 LIPG

4.18e-0419322GO:0008970
GeneOntologyMolecularFunctionphospholipase activity

SMPDL3B PLA2G15 LIPG

7.97e-04114323GO:0004620
GeneOntologyMolecularFunctionoutward rectifier potassium channel activity

KCNA3 KCNK17

8.52e-0427322GO:0015271
GeneOntologyMolecularFunctionretinoic acid binding

UGT2B15 UGT2B17

9.16e-0428322GO:0001972
GeneOntologyMolecularFunctionlipase activity

SMPDL3B PLA2G15 LIPG

1.38e-03138323GO:0016298
GeneOntologyMolecularFunctionretinoid binding

UGT2B15 UGT2B17

2.68e-0348322GO:0005501
GeneOntologyMolecularFunctionisoprenoid binding

UGT2B15 UGT2B17

2.79e-0349322GO:0019840
GeneOntologyMolecularFunctionO-acyltransferase activity

CROT PLA2G15

4.02e-0359322GO:0008374
GeneOntologyBiologicalProcesscellular glucuronidation

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

9.18e-1121305GO:0052695
GeneOntologyBiologicalProcessglucuronate metabolic process

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

2.95e-1026305GO:0019585
GeneOntologyBiologicalProcessuronic acid metabolic process

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

2.95e-1026305GO:0006063
GeneOntologyBiologicalProcessmonocarboxylic acid metabolic process

UGT2A2 UGT2B15 UGT2B17 CROT PLA2G15 LIPG UGT2A3 UGT2A1

7.01e-06731308GO:0032787
GeneOntologyBiologicalProcesscarboxylic acid metabolic process

UGT2A2 UGT2B15 UGT2B17 CROT ASRGL1 PLA2G15 LIPG UGT2A3 UGT2A1

1.07e-051035309GO:0019752
GeneOntologyBiologicalProcessoxoacid metabolic process

UGT2A2 UGT2B15 UGT2B17 CROT ASRGL1 PLA2G15 LIPG UGT2A3 UGT2A1

1.28e-051058309GO:0043436
GeneOntologyBiologicalProcessorganic acid metabolic process

UGT2A2 UGT2B15 UGT2B17 CROT ASRGL1 PLA2G15 LIPG UGT2A3 UGT2A1

1.34e-051064309GO:0006082
GeneOntologyBiologicalProcessbiphenyl catabolic process

UGT2B15 UGT2B17

5.70e-058302GO:0070980
GeneOntologyBiologicalProcessestrogen metabolic process

UGT2B15 UGT2B17 UGT2A3

5.85e-0552303GO:0008210
GeneOntologyBiologicalProcessphospholipid catabolic process

SMPDL3B PLA2G15 LIPG

8.98e-0560303GO:0009395
GeneOntologyBiologicalProcessbiphenyl metabolic process

UGT2B15 UGT2B17

9.14e-0510302GO:0018879
GeneOntologyBiologicalProcessxenobiotic glucuronidation

UGT2B15 UGT2B17

1.34e-0412302GO:0052697
GeneOntologyBiologicalProcesssteroid metabolic process

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.92e-04376305GO:0008202
GeneOntologyBiologicalProcesscellular catabolic process

UGT2B15 UGT2B17 CROT ASRGL1 SMPDL3B MAPT PLA2G15 LIPG

3.19e-041253308GO:0044248
GeneOntologyBiologicalProcessregulation of tubulin deacetylation

YEATS2 MAPT

4.64e-0422302GO:0090043
GeneOntologyBiologicalProcesstubulin deacetylation

YEATS2 MAPT

5.53e-0424302GO:0090042
GeneOntologyBiologicalProcessregulation of protein deacetylation

YEATS2 MAPT

1.11e-0334302GO:0090311
GeneOntologyBiologicalProcesscentrosome localization

PKHD1 PLXNA2

1.18e-0335302GO:0051642
GeneOntologyBiologicalProcessmicrotubule organizing center localization

PKHD1 PLXNA2

1.25e-0336302GO:0061842
GeneOntologyBiologicalProcessbenzene-containing compound metabolic process

UGT2B15 UGT2B17

1.32e-0337302GO:0042537
GeneOntologyBiologicalProcessxenobiotic catabolic process

UGT2B15 UGT2B17

1.32e-0337302GO:0042178
GeneOntologyBiologicalProcessandrogen metabolic process

UGT2B15 UGT2B17

1.39e-0338302GO:0008209
DomainUDPGT

UGT2B15 UGT2B17 UGT2A3 UGT2A1

3.18e-0821304PS00375
DomainUDPGT

UGT2B15 UGT2B17 UGT2A3 UGT2A1

3.18e-0821304PF00201
DomainUDP_glucos_trans

UGT2B15 UGT2B17 UGT2A3 UGT2A1

3.18e-0821304IPR002213
DomainIPT

PKHD1 NFATC2 PLXNA2

1.07e-0527303SM00429
DomainTIG

PKHD1 NFATC2 PLXNA2

1.63e-0531303PF01833
DomainIPT

PKHD1 NFATC2 PLXNA2

1.80e-0532303IPR002909
DomainIg_E-set

PKHD1 NFATC2 PLXNA2

6.10e-04104303IPR014756
Domain-

PLA2G15 LIPG

1.56e-021193023.40.50.1820
DomainAB_hydrolase

PLA2G15 LIPG

1.56e-02119302IPR029058
PathwayREACTOME_GLUCURONIDATION

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

3.81e-1024245MM14599
PathwayWP_GLUCURONIDATION

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

4.76e-1025245MM15820
PathwayREACTOME_GLUCURONIDATION

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

4.76e-1025245M17787
PathwayWP_GLUCURONIDATION

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

5.89e-1026245M39404
PathwayREACTOME_ASPIRIN_ADME

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

9.53e-0944245M45014
PathwayREACTOME_ASPIRIN_ADME

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.07e-0845245MM15694
PathwayKEGG_ASCORBATE_AND_ALDARATE_METABOLISM

UGT2B15 UGT2B17 UGT2A3 UGT2A1

7.98e-0825244M605
PathwayKEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.29e-0728244M19580
PathwayKEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM

UGT2B15 UGT2B17 UGT2A3 UGT2A1

6.27e-0741244M7399
PathwayREACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

8.69e-07107245MM14595
PathwayREACTOME_DRUG_ADME

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

9.53e-07109245M45012
PathwayREACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

9.53e-07109245M18788
PathwayREACTOME_DRUG_ADME

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.47e-06119245MM15692
PathwayKEGG_DRUG_METABOLISM_OTHER_ENZYMES

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.53e-0651244M17726
PathwayKEGG_STARCH_AND_SUCROSE_METABOLISM

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.66e-0652244M14171
PathwayKEGG_STEROID_HORMONE_BIOSYNTHESIS

UGT2B15 UGT2B17 UGT2A3 UGT2A1

2.08e-0655244M14933
PathwayKEGG_RETINOL_METABOLISM

UGT2B15 UGT2B17 UGT2A3 UGT2A1

3.83e-0664244M9488
PathwayKEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450

UGT2B15 UGT2B17 UGT2A3 UGT2A1

5.50e-0670244M16794
PathwayKEGG_DRUG_METABOLISM_CYTOCHROME_P450

UGT2B15 UGT2B17 UGT2A3 UGT2A1

6.15e-0672244M9257
PathwayWP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.21e-05183245M39588
PathwayREACTOME_BIOLOGICAL_OXIDATIONS

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

2.89e-05219245MM14838
PathwayREACTOME_BIOLOGICAL_OXIDATIONS

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

2.95e-05220245M10320
PathwayREACTOME_PREDNISONE_ADME

UGT2B15 UGT2B17

6.88e-0423242MM16639
PathwayREACTOME_PARACETAMOL_ADME

UGT2B15 UGT2B17

1.98e-0339242MM15695
Pubmed

Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3.

UGT2A2 UGT2A3 UGT2A1

7.07e-10332319858781
Pubmed

The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.

TINAGL1 BOC LAYN KCNK17 CRISPLD1 PLA2G15 LIPG PLXNA2 UGT2A3 EDEM2

1.16e-08985321012975309
Pubmed

The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.

UGT2B15 UGT2B17 UGT2A1

3.95e-08832318719240
Pubmed

Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.

UGT2B15 UGT2B17

8.20e-07232224267955
Pubmed

Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression.

UGT2B15 UGT2B17

8.20e-07232222170718
Pubmed

Expression of UDP Glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells.

UGT2B15 UGT2B17

8.20e-07232232660355
Pubmed

The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste.

UGT2A2 UGT2A1

8.20e-07232235039640
Pubmed

Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5.

UGT2B15 UGT2B17

8.20e-0723223105095
Pubmed

UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells.

UGT2B15 UGT2B17

8.20e-07232217848572
Pubmed

Rat olfactory bulb and epithelium UDP-glucuronosyltransferase 2A1 (UGT2A1) expression: in situ mRNA localization and quantitative analysis.

UGT2A2 UGT2A1

8.20e-07232211376859
Pubmed

Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.

UGT2B15 UGT2B17

8.20e-07232227496708
Pubmed

The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence.

UGT2B15 UGT2B17

8.20e-0723221909870
Pubmed

Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation.

UGT2B15 UGT2B17

8.20e-07232228228532
Pubmed

Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications.

UGT2B15 UGT2B17

8.20e-07232224121496
Pubmed

Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase.

UGT2A2 UGT2A1

8.20e-07232210359671
Pubmed

Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium.

UGT2B15 UGT2B17

8.20e-07232215666817
Pubmed

Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation.

UGT2B15 UGT2B17

8.20e-0723223117546
Pubmed

The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.

UGT2B15 UGT2B17

8.20e-07232217698910
Pubmed

Catalog of 86 single-nucleotide polymorphisms (SNPs) in three uridine diphosphate glycosyltransferase genes: UGT2A1, UGT2B15, and UGT8.

UGT2B15 UGT2A1

2.46e-06332212376738
Pubmed

Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism.

UGT2B15 UGT2B17

2.46e-06332219572376
Pubmed

Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines.

UGT2B15 UGT2B17

2.46e-06332226163549
Pubmed

Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells.

UGT2B15 UGT2B17

2.46e-06332217988216
Pubmed

Forkhead box protein A1 regulates UDP-glucuronosyltransferase 2B15 gene transcription in LNCaP prostate cancer cells.

UGT2B15 UGT2B17

2.46e-06332220736324
Pubmed

Tissue distribution and relative gene expression of UDP-glucuronosyltransferases (2B7, 2B15, 2B17) in the human fetus.

UGT2B15 UGT2B17

2.46e-06332223223495
Pubmed

Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer.

UGT2B15 UGT2B17

2.46e-06332226385605
Pubmed

Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes.

UGT2B15 UGT2B17

2.46e-06332218302198
Pubmed

Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study.

UGT2B15 UGT2B17

2.46e-06332228882566
Pubmed

The nuclear receptor Shp regulates morphine withdrawal syndrome via modulation of Ugt2b expression in mice.

UGT2B15 UGT2B17

2.46e-06332230689982
Pubmed

The Human UDP-glucuronosyltransferase UGT2A1 and UGT2A2 enzymes are highly active in bile acid glucuronidation.

UGT2A2 UGT2A1

2.46e-06332223756265
Pubmed

A mouse knockout library for secreted and transmembrane proteins.

TINAGL1 BOC LAYN CRISPLD1 PLA2G15 PLXNA2

3.51e-0646032620562862
Pubmed

Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells.

UGT2B15 UGT2B17

4.92e-06432218281521
Pubmed

Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.

UGT2B15 UGT2B17

4.92e-06432226176234
Pubmed

Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily.

UGT2A2 UGT2A1

8.19e-06532216141793
Pubmed

Steroidogenic enzymes and stem cell markers are upregulated during androgen deprivation in prostate cancer.

UGT2B15 UGT2B17

1.23e-05632221365123
Pubmed

Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-Tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation.

CKB MAPT

1.23e-05632216443603
Pubmed

Weak activity of UDP-glucuronosyltransferase toward Bisphenol analogs in mouse perinatal development.

UGT2B15 UGT2B17

1.72e-05732226074487
Pubmed

Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometry.

UGT2B15 UGT2B17

2.29e-05832222579593
Pubmed

Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT.

UGT2B15 UGT2B17

2.29e-05832232093886
Pubmed

Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine.

UGT2B15 UGT2A1

2.29e-05832210748067
Pubmed

Associations between polymorphisms in glucuronidation and sulfation enzymes and mammographic breast density in premenopausal women in the United States.

UGT2B15 UGT2B17

2.29e-05832220142249
Pubmed

Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.

CKB PKHD1 YEATS2 KCNA3

3.92e-0520832433230847
Pubmed

The miR-379/miR-410 cluster at the imprinted Dlk1-Dio3 domain controls neonatal metabolic adaptation.

UGT2B15 UGT2B17 CROT

4.04e-057232325124681
Pubmed

Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans.

UGT2B15 UGT2B17

5.38e-051232220308471
Pubmed

Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression.

NFATC2 MAPT

1.39e-041932220219685
Pubmed

Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.

CKB ASRGL1 SMPDL3B KCNK17 CRISPLD1 UGT2A3 EDEM2

1.44e-04129332715342556
Pubmed

Identification of anchor genes during kidney development defines ontological relationships, molecular subcompartments and regulatory pathways.

UGT2B15 UGT2B17 TMEM45A

7.87e-0419732321386911
InteractionUGT2A3 interactions

UGT2A2 UGT2B15 UGT2A3

7.25e-086323int:UGT2A3
InteractionUGT2B15 interactions

UGT2B15 UGT2A3 UGT2A1

7.25e-086323int:UGT2B15
InteractionUGT2A2 interactions

UGT2A2 UGT2A3

2.44e-062322int:UGT2A2
InteractionUGT2A1 interactions

UGT2B15 UGT2A1

7.32e-063322int:UGT2A1
InteractionRIMS1 interactions

CKB KCNA3 MAPT

3.45e-0540323int:RIMS1
InteractionFBXO2 interactions

TINAGL1 BOC MAPT PLA2G15 PLXNA2 EDEM2

4.01e-05411326int:FBXO2
CytobandEnsembl 112 genes in cytogenetic band chr4q13

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

8.20e-08157325chr4q13
Cytoband4q13

UGT2B15 UGT2B17 UGT2A1

1.39e-07153234q13
CytobandEnsembl 112 genes in cytogenetic band chr1p35

TINAGL1 SMPDL3B

4.13e-03137322chr1p35
Cytoband19q13.2

SPHK2 LGALS4

5.86e-0316432219q13.2
GeneFamilyUDP glucuronosyltransferases

UGT2A2 UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.43e-1032195363
ToppCell3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB PKHD1 UGT2B17 LIPG UGT2A1

1.13e-07164325ea02ca343b2b28e437304de889e2ae1e315a1197
ToppCellE18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_A|E18.5-samps / Age Group, Lineage, Cell class and subclass

CKB UGT2A2 GUCY1B2 UGT2A1

3.76e-061483245729826e8d45bf995e2efa6707c49e264d12d112
ToppCell3'-GW_trimst-1.5-LargeIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB UGT2B15 UGT2A3 LGALS4

8.34e-061813241c04e53f46992a0aea9d3eee985681ec4e71f80d
ToppCell3'-GW_trimst-1.5-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB UGT2B15 UGT2A3 LGALS4

8.34e-0618132483adf61f44cebe9e75de175c5dc39237fbf9ed24
ToppCelldroplet-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CKB CROT TMEM45A PLXNA2

9.29e-061863242913b5fd0617d024d600ba7015ec7b1961dade83
ToppCell3'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB UGT2B17 UGT2A3 LGALS4

9.69e-06188324d00f48afed62fc60d3530bb3b80ac0162b0b0ed8
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PKHD1 BOC LIPG UGT2A3

9.89e-06189324904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell3'-GW_trimst-1.5-LargeIntestine|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB UGT2B17 UGT2A3 LGALS4

1.05e-051923249946f5d5cab64936ca68d9f4dc9ce6eba85b43ab
ToppCell3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TINAGL1 ASRGL1 LIPG PLXNA2

1.07e-051933241e6e2d786511cc40241197368f5df20c20b882f3
ToppCelldroplet-Tongue-TONGUE-1m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CKB CROT TMEM45A PLXNA2

1.10e-05194324a3adcdc8b87332e8beb9bcd70cf36424af10633d
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TINAGL1 PKHD1 GUCY1B2 UGT2A3

1.10e-051943248ddcaaf24cee6e30d5be52c0cbf778cfba309c53
ToppCell(6)_Endothelial-B_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

TINAGL1 ASRGL1 LIPG PLXNA2

1.10e-051943240cf4e67d4024652794b5bfdd4a71a7d98900b4c8
ToppCell5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB UGT2B17 UGT2A3 LGALS4

1.12e-051953249c24ebce2e3e00b8b692c62a22a53b7d59f0eabb
ToppCell3'-GW_trimst-1.5-LargeIntestine-Epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB UGT2B17 UGT2A3 LGALS4

1.14e-051963240df0dbe60e6f643912e5ff30c22415a0513f9bf1
ToppCell3'-GW_trimst-1.5-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB UGT2B17 UGT2A3 LGALS4

1.14e-05196324153326be031a58b720da4dab57edd8936d513f8e
ToppCell3'-GW_trimst-1.5-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB UGT2B17 UGT2A3 LGALS4

1.14e-05196324b7748618aaf3ace40940be1b6ca2148e941541a2
ToppCell5'-GW_trimst-2-LargeIntestine-Epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB UGT2B17 UGT2A3 LGALS4

1.14e-0519632479bc7ab96b52b2a542348a13ddd0a4f095698c5e
ToppCell5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB UGT2B17 UGT2A3 LGALS4

1.16e-05197324a6a27e5809ee2c9b56c7e06c35e4f140f9fa13ad
ToppCelldistal-1-Endothelial-Bronchial_Vessel_2|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

TINAGL1 ASRGL1 LIPG PLXNA2

1.24e-05200324aa8f8a0271c1363981e6ca1b2c1f0a8eb2652602
ToppCellTCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9

UGT2B15 UGT2A3 LGALS4

9.79e-05125323b82ce58b6262b0739c788395766e5fc77d2744f2
ToppCellCOVID-19_Mild-Classical_Monocyte-|Classical_Monocyte / Disease condition and Cell class

KCNA3 MAPT LIPG

1.07e-0412932323b07c71142979d2178fd3a3cdeb3cde73c72c3d
ToppCellCOVID-19_Mild-Classical_Monocyte-|COVID-19_Mild / Disease condition and Cell class

KCNA3 MAPT LIPG

1.12e-04131323ae5eb9c013674b36987bf26d4f752dbb374f547b
ToppCellClub_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id

UGT2B15 TMEM45A UGT2A1

1.31e-04138323133015953fc660d00339f47b415da5e9872313a2
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

UGT2A2 TMEM45A MAPT

1.78e-041533233240d4d690335ba22317b1f3d33f9ea069e93838
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

UGT2A2 TMEM45A MAPT

1.78e-04153323edf5d026e8e4c685b7c369d70894741bb2cd568e
ToppCellTCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9

PKHD1 UGT2A3 UGT2A1

1.81e-0415432389a60a79d07466d7ad05888d10a72d3b1ab384af
ToppCellTCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9

PKHD1 UGT2A3 UGT2A1

1.81e-04154323f1fea1a87e977221fa125b62287368be9af4987d
ToppCellTCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9

PKHD1 UGT2A3 UGT2A1

1.81e-04154323b5604c0b0b9b283352a3f612f40883b9123475d1
ToppCellTCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal-1|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9

PKHD1 UGT2A3 UGT2A1

1.81e-04154323160b170a3ade8b246843c9854af332475c047ba0
ToppCell5'-Adult-Appendix-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PKHD1 ASRGL1 LIPG

1.88e-0415632358b9520fce6e259b36c3d59e82b712f5e7729e3e
ToppCellChildren_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

TINAGL1 CROT PLXNA2

1.92e-041573236ee2692f705bdd93ba523dffaf2f0cd921b47e28
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PKHD1 BOC LIPG

1.96e-041583231cefb82b9bf79c687a119be568cfc15b14c6e040
ToppCell343B-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

TINAGL1 BOC LAYN

2.07e-04161323da9eecf919866a9c579d7a707a996cf335213134
ToppCell343B-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

TINAGL1 BOC LAYN

2.07e-04161323d431625c32f59a6b552191f3adc5198bd16ad5cf
ToppCelldroplet-Kidney-nan-21m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CKB SMPDL3B PLA2G15

2.18e-04164323d4cdcd61e8c28b3fb912cef8837cc1a49678a729
ToppCelldroplet-Marrow-BM-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CKB SMPDL3B LIPG

2.18e-04164323758e85e2f5e7236b345e16c78344d5e0bf17d8dc
ToppCellMultiple_Sclerosis-Other-HSPC|Multiple_Sclerosis / Disease, Lineage and Cell Type

SMPDL3B KCNK17 CRISPLD1

2.18e-041643236af5529507d695b347adee4be5ead70f56c9cf55
ToppCelldroplet-Kidney-nan-21m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CKB SMPDL3B PLA2G15

2.22e-041653239852a4cb680af39c92c7d2d5e5fa8dc04e6602aa
ToppCelldroplet-Kidney-nan-21m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CKB SMPDL3B PLA2G15

2.22e-04165323c629ed33ff14834c32cc1a91116fb079f7aaa94d
ToppCell5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB ASRGL1 UGT2A3

2.26e-04166323fe006c67a96ffa5a84fba2db96228234668b2a79
ToppCellfacs-Marrow-KLS-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CKB MAPT LIPG

2.26e-04166323aa2df07eff323ded751ced8938af08223d7f2029
ToppCellwk_20-22-Epithelial-Airway_epithelial_progenitor|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

CKB SMPDL3B UGT2A3

2.26e-04166323fcd0bd70b553789092249806ace324b77bd10481
ToppCellfacs-Marrow-KLS-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CKB MAPT LIPG

2.26e-04166323695298a94d62b8adab083900003ec636fbaae5d9
ToppCellFetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

TINAGL1 ASRGL1 LIPG

2.26e-04166323f7926ee266dcbf10df375cd921f1db5a2fa604f8
ToppCellBasal_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id

TINAGL1 LAYN UGT2A1

2.26e-0416632323c04d1fba0c1733ccd0e4378fae2edde4fd0a7b
ToppCellwk_20-22-Epithelial-Airway_epithelial_progenitor-epi-stalk_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

CKB SMPDL3B UGT2A3

2.26e-04166323b60954e5625743657d0fd9264b738b46e72fd8a6
ToppCelldroplet-Marrow-nan-24m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CKB SMPDL3B LIPG

2.26e-04166323b3d9b61847c6c96b8cb28b8a6aeda52f43c706ab
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TINAGL1 LAYN TMEM45A

2.34e-041683232eed7dc1a2aff11be024823c4323c42bc94362f6
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

BOC CROT UGT2A1

2.43e-041703232d880223d01bde4bf777bd6f50b7d2768489075f
ToppCellfacs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TINAGL1 TMEM45A PLXNA2

2.43e-0417032367d7e1da3ebd2d14cb2e67799e94d655027ed5c4
ToppCellfacs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TINAGL1 TMEM45A PLXNA2

2.43e-041703238e1f757ed62218c0fb6525f49d142dd2cd29acf9
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PKHD1 BOC LIPG

2.43e-041703235d5f208682be21ed58320f5fc083a7898f8712da
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

BOC CROT UGT2A1

2.43e-041703230cc20322cb3e3e7bbd4daad8785c99f80e355c16
ToppCell3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB UGT2A3 LGALS4

2.47e-04171323f2b31c97bbcc5164fc279ed0362007878887ad5e
ToppCell3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB UGT2A3 LGALS4

2.47e-041713233a2fefcb62e9d47ae6b3a946c45d3f2dd32c576c
ToppCell3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB UGT2A3 LGALS4

2.47e-041713233ef44a5e3e8f81424f1e9aa302860b6688a549b8
ToppCell3'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB SMPDL3B LGALS4

2.47e-04171323317b70d72a4ca5336cfb6a49dc57f8e2a8a1c736
ToppCellHealthy_donor-HSPC|Healthy_donor / disease group, cell group and cell class (v2)

SMPDL3B KCNK17 CRISPLD1

2.51e-04172323bc7549faadfc92c683c0e26bea380458706774b5
ToppCellPND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TINAGL1 TMEM45A CRISPLD1

2.51e-04172323fc092a0631555d79e00ef9890cbd806e15bca2d4
ToppCelldroplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CKB SMPDL3B LIPG

2.51e-041723237295bf3ae21a61dd6bcfa0dfb7a37d0f3e8f94ab
ToppCellPND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TINAGL1 TMEM45A CRISPLD1

2.51e-04172323745725bd10c82017d678463b8fef0d2dcf09a8fd
ToppCell3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TINAGL1 MAPT EDEM2

2.51e-04172323107417cfab7775bc1f80807115047abfb50b7a7e
ToppCelldroplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CKB NFATC2 QRICH2

2.55e-04173323b6aed736d8480e3a6a5718aabd2fb79b1b75fa48
ToppCell3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB UGT2A3 LGALS4

2.55e-04173323021457c7bdb55de7351e43322d360e8fd7061658
ToppCell3'-GW_trimst-1-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB UGT2B15 LGALS4

2.60e-04174323ca067e8ec55bbc3deafc09f08bc13af08364d165
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HIVEP1 NFATC2 CRISPLD1

2.60e-0417432399eb5e1aee136c7039e23b68a43a0fa3d775859f
ToppCell3'-GW_trimst-1-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB PKHD1 LGALS4

2.64e-041753238727252bcbc70bfa2ff72e7421df9cfe6fd4eed7
ToppCell3'-GW_trimst-1-LargeIntestine-Epithelial-Tuft-related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB PKHD1 LGALS4

2.64e-04175323c083abe368e5c0dc2b0f27f375c9271a2d7ff64f
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PKHD1 BOC LIPG

2.69e-04176323327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCellwk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

BOC KCNA3 CRISPLD1

2.69e-041763231af28b701c4598ce761f85adbd5d79e4918d265a
ToppCelldroplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TINAGL1 MAPT LIPG

2.69e-04176323e2b59a904c5c8f9c88e1e63788e9b6485f22edd0
ToppCelldroplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TINAGL1 MAPT LIPG

2.69e-04176323f931192e3cc65414e2245354f443473696cc7ce8
ToppCell10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-chondrocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

BOC TMEM45A CRISPLD1

2.73e-04177323915b848d789051a1c3bc6f6dc86955bb752276ab
ToppCellPND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TINAGL1 TMEM45A CRISPLD1

2.73e-041773236f6cf93893daac6ae228df36219ee3acf8de8f97
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PKHD1 BOC LIPG

2.73e-04177323da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PKHD1 BOC LIPG

2.78e-04178323c20f050344a2e120e685e2a7fe36c6dfc1dc37b6
ToppCellfacs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TINAGL1 CRISPLD1 PLXNA2

2.78e-041783239f59a9af232d77bb55603a7776dbf9749ea652f2
ToppCell367C-Endothelial_cells-Endothelial-B_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells)

TINAGL1 ASRGL1 UGT2A1

2.78e-04178323e1e96a0e3ff718ebf676a982bc63e8ced6984059
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KCNA3 PLA2G15 EDEM2

2.78e-041783230b398656f26c4061b11ccf98908d0e2e1367585a
ToppCelldroplet-Bladder-BLADDER-1m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NFATC2 MAPT CRISPLD1

2.78e-041783236bef4ef48f649c6e38ae732bc08e6d7814db588b
ToppCell367C-Endothelial_cells-Endothelial-B_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells)

TINAGL1 ASRGL1 UGT2A1

2.78e-04178323363e8b23b3834692a8a79e5fdc7b43bd3a4dab5e
ToppCellIIH-matDC|IIH / Condition, Cell_class and T cell subcluster

CKB BOC CRISPLD1

2.82e-041793235999c85ce3bab5309ff1ed154be7e32b037750b1
ToppCellIIH-matDC-|IIH / Condition, Cell_class and T cell subcluster

CKB BOC CRISPLD1

2.82e-0417932346074b2781ed79e2979428b3ec81504621d3903c
ToppCell3'_v3-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue

ASRGL1 KCNK17 CRISPLD1

2.87e-04180323b37ee81b792213d6595b4ec65d04bc35d83321c7
ToppCellCOVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type

PKHD1 MAPT UGT2A3

2.87e-04180323864c895b5eaedefae86f5829fa344f7b686fb59f
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TINAGL1 TMEM45A CRISPLD1

2.87e-041803239c47852c0a723e2f5cd6898afff4c31a0da06905
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TINAGL1 TMEM45A CRISPLD1

2.87e-04180323499d5fe71e0dc20cffdf85e3b3f14eb4e83e3a3d
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TINAGL1 TMEM45A CRISPLD1

2.87e-041803232405aa5699a8d8cf4c6b3dca07510e774728ac50
ToppCell5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB UGT2B17 LGALS4

2.91e-04181323bec917f6f56ae252639a5a76024be5df5c70a6d5
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PKHD1 BOC LIPG

2.91e-04181323071f9bb5d39070cdc473d9b0e094d196bc702b56
ToppCell3'_v3-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue

ASRGL1 KCNK17 CRISPLD1

2.91e-0418132330ec4635474ee0f0ea1415ec0ba7f008d97e8c1a
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PKHD1 LIPG UGT2A3

2.91e-041813236956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCell5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB TINAGL1 PLXNA2

2.96e-0418232337547b36264090b49a193a8ef3a8d88e647f0b79
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PKHD1 BOC UGT2A3

2.96e-041823235e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PKHD1 BOC LIPG

3.01e-04183323738e94b50c4c08c727d4eed0708dda08aa6891b4
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PKHD1 BOC LIPG

3.01e-0418332392fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PKHD1 BOC LIPG

3.06e-04184323da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8
ToppCellwk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

PKHD1 QRICH2 PLXNA2

3.11e-04185323636505a3d96f75d951ab42bcf8af6ae07abc732d
ToppCell10x5'-GI_large-bowel-Lymphocytic_B_plasma-Plasma_cells|GI_large-bowel / Manually curated celltypes from each tissue

SMPDL3B TMEM45A EDEM2

3.11e-041853232cad994207c4afc9d70f4c2d243ffbbcdbba693e
ToppCell10x5'-GI_large-bowel-Lymphocytic_B_plasma|GI_large-bowel / Manually curated celltypes from each tissue

SMPDL3B TMEM45A EDEM2

3.11e-04185323989583c487d8c121e3731faf68f863ba43a582e6
DrugC1 11-32

UGT2B15 UGT2B17 UGT2A3 UGT2A1

9.70e-0918324CID000443077
DrugC11131

UGT2B15 UGT2B17 UGT2A3 UGT2A1

9.70e-0918324CID000443076
DrugT4-G

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.23e-0819324CID000152424
Drugestriol-16-glucuronide

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.89e-0821324CID000122281
Drugestradiol-3-glucuronide

UGT2B15 UGT2B17 UGT2A3 UGT2A1

2.79e-0823324CID000066651
DrugL-idaro-1,4-lactone

UGT2B15 UGT2B17 UGT2A3 UGT2A1

6.42e-0828324CID000078997
Drug7-hydroxycoumarin glucuronide

UGT2B15 UGT2B17 UGT2A3 UGT2A1

7.44e-0829324CID000125641
DrugAC1Q6OQG

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.28e-0733324CID000009686
DrugAC1NOWCJ

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.63e-0735324CID005120112
Drug3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.63e-0735324CID010436171
Drugestrone-3-glucuronide

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.63e-0735324CID000115255
Drugharmol

UGT2B15 UGT2B17 UGT2A3 UGT2A1

2.83e-0740324CID000068094
Drugtestosterone glucuronide

UGT2B15 UGT2B17 UGT2A3 UGT2A1

3.14e-0741324CID000108192
Drug2-AF

UGT2B15 UGT2B17 UGT2A3 UGT2A1

3.14e-0741324CID000005800
Drugandrosterone glucuronide

UGT2B15 UGT2B17 UGT2A3 UGT2A1

3.82e-0743324CID000114833
DrugAC1NQGK1

UGT2B15 UGT2B17 UGT2A3 UGT2A1

8.30e-0752324CID005195977
Drugoxazepam

UGT2B15 UGT2B17 UGT2A3 UGT2A1

8.96e-0753324CID000004616
Drug7-methoxycoumarin

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.20e-0657324CID000010748
Drugphenolphthalein

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.29e-0658324CID000004764
Drugurochloralic acid

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.39e-0659324CID003036914
Drug4-hydroxybiphenyl

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.39e-0659324CID000007103
DrugSN-38G

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.39e-0659324CID000443154
DrugUDP-alpha-d-xylopyranose

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.48e-0660324CID000001165
Drug3-OHBaP

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.81e-0663324CID000025890
DrugMeldola

UGT2B15 UGT2B17 UGT2A3 UGT2A1

2.46e-0668324CID000081507
Drugmethoxyresorufin

UGT2B15 UGT2B17 UGT2A3 UGT2A1

2.61e-0669324CID000119220
Drug2,2,2-trichloroethanol

UGT2B15 UGT2B17 UGT2A3 UGT2A1

3.27e-0673324CID000008259
Drug7-hydroxycoumarin

UGT2B15 UGT2B17 UGT2A3 UGT2A1

3.64e-0675324CID005281426
Drug16-epiestriol

UGT2B15 UGT2B17 UGT2A3 UGT2A1

4.05e-0677324CID000003269
DrugAC1N8H7N

UGT2B15 UGT2B17 UGT2A3 UGT2A1

4.26e-0678324CID004318740
Drugbenzyloxyresorufin

UGT2B15 UGT2B17 UGT2A3 UGT2A1

4.26e-0678324CID000114982
DrugHymecromone

UGT2B15 UGT2B17 UGT2A1

5.68e-0625323ctd:D006923
Drugpentoxyresorufin

UGT2B15 UGT2B17 UGT2A3 UGT2A1

6.59e-0687324CID000107683
Drugp-nitroanisole

UGT2B15 UGT2B17 UGT2A3 UGT2A1

8.23e-0692324CID000007485
Drug2-naphthol

UGT2B15 UGT2B17 UGT2A3 UGT2A1

8.59e-0693324CID000008663
DrugDCNB

UGT2B15 UGT2B17 UGT2A3 UGT2A1

9.35e-0695324CID000007443
Drug1-naphthol

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.06e-0598324CID000007005
Drug16-hydroxyestrone

CKB UGT2B15

1.15e-054322ctd:C026702
Drug3-hydroxyandrostan-17-one

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.24e-05102324CID000000225
DrugBP-3,6-quinol

UGT2B15 UGT2B17 UGT2A1

1.34e-0533323CID000119292
Drug2-methoxyestradiol

BOC UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.84e-05236325CID000001573
Drugl-borneol

UGT2B15 UGT2B17 UGT2A1

1.90e-0537323CID000010049
DrugAC1Q7AUJ

UGT2B15 UGT2B17 UGT2A3 UGT2A1

2.13e-05117324CID000003303
Drugalpha-naphthoflavone

UGT2B15 UGT2B17 UGT2A3 UGT2A1

2.20e-05118324CID000011790
Drugbenzphetamine

UGT2B15 UGT2B17 UGT2A3 UGT2A1

2.28e-05119324CID000002341
Druglorcaserin

UGT2B15 UGT2B17

2.86e-056322ctd:C506658
Drughexobarbital

UGT2B15 UGT2B17 UGT2A3 UGT2A1

2.94e-05127324CID000003608
Drug7,8-benzoquinoline

UGT2B15 UGT2B17 UGT2A1

3.00e-0543323CID000009191
DrugMS-222

UGT2B15 UGT2B17 UGT2A1

3.21e-0544323CID000011400
Drug4-methylumbelliferone

UGT2B15 UGT2B17 UGT2A3 UGT2A1

3.42e-05132324CID003364573
Drugpivaloylcarnitine

CROT PLXNA2

4.00e-057322CID000126894
Drugsalicylamide

UGT2B15 UGT2B17 UGT2A1

4.18e-0548323CID000005147
Drugpheophytin

CKB UGT2B15 UGT2B17 UGT2A3 UGT2A1

4.45e-05284325CID000000250
Druganiline

UGT2B15 UGT2B17 UGT2A3 UGT2A1

4.55e-05142324CID000006115
Drugscopoletin

UGT2B15 UGT2B17 UGT2A1

4.73e-0550323CID005280460
DrugAC1L9HFF

BOC ASRGL1 LGALS4

6.30e-0555323CID000445102
DrugAC1LCF1F

UGT2B15 UGT2B17 UGT2A3 UGT2A1

7.42e-05161324CID000627275
Drug4-hydroxyestrone

UGT2B15 UGT2B17 UGT2A1

7.77e-0559323CID000018418
Drugacetaminophen glucuronide

UGT2B15 UGT2B17 UGT2A1

7.77e-0559323CID000083944
Drugestrone-d4

UGT2B15 UGT2B17 UGT2A3 UGT2A1

8.75e-05168324CID000000698
Drugaminopyrine

UGT2B15 UGT2B17 UGT2A3 UGT2A1

9.37e-05171324CID000006009
Drugglucosiduronate

UGT2B15 UGT2B17 UGT2A3 UGT2A1

9.37e-05171324CID000000610
Drug4-nitrophenol

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.07e-04177324CID000000980
Drugdioxin

UGT2B15 UGT2B17 UGT2A3 LGALS4 UGT2A1

1.15e-04347325CID000015625
DrugSN-38

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.24e-04184324CID000104842
DrugNSC9700

TINAGL1 BOC UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.35e-04578326CID000005408
DrugDNCB

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.38e-04189324CID000000006
Druguridine 5'-diphosphoglucuronic acid

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.38e-04189324CID000000390
Drugeugenol

UGT2B15 UGT2B17 UGT2A1

1.47e-0473323CID000003314
Drug2-hydroxyestrone

CKB UGT2B15

1.48e-0413322ctd:C024980
DrugMegestrol acetate [595-33-5]; Down 200; 10.4uM; PC3; HT_HG-U133A

TINAGL1 SMPDL3B MAPT PLXNA2

1.52e-041943246667_DN
Drugdimethylnitrosamine

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.59e-04196324CID000006124
DrugTetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A

TINAGL1 HIVEP1 MAPT LIPG

1.59e-041963245757_DN
DrugAC1MRR4B

CKB BOC SPHK2 PLA2G15

1.68e-04199324CID003522484
Drugbeta-naphthoflavone

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.71e-04200324CID000002361
DrugUDP-N-acetylglucosamine

UGT2B15 UGT2B17 UGT2A3 UGT2A1

1.81e-04203324CID000001167
Drugacridine

UGT2B15 UGT2B17 UGT2A1

2.00e-0481323CID000009215
DrugAroclor 1254

UGT2B15 UGT2B17 UGT2A3 UGT2A1

2.18e-04213324CID000040470
Drug5 alpha-androstane

UGT2B15 UGT2B17 UGT2A1

2.22e-0484323CID000094144
DrugAC1NRA2O

CROT MAPT LIPG

2.22e-0484323CID005287668
Drug7-ethoxycoumarin

UGT2B15 UGT2B17 UGT2A1

2.38e-0486323CID000035703
Drugmenthol

UGT2B15 UGT2B17 UGT2A1

2.47e-0487323CID000001254
DrugAndrostane-3,17-diol

UGT2B15 UGT2B17

2.89e-0418322ctd:D015113
Drug4-aminobiphenyl

UGT2B15 UGT2B17 UGT2A1

2.91e-0492323CID000007102
Drug3-methylcholanthrene

UGT2B15 UGT2B17 UGT2A3 UGT2A1

2.97e-04231324CID000001674
DrugUDP - Na

UGT2B15 UGT2B17 UGT2A3 UGT2A1

3.17e-04235324CID000001158
Drugethoxyresorufin

UGT2B15 UGT2B17 UGT2A1

3.20e-0495323CID000003294
DrugDB04103

UGT2B15 UGT2B17 UGT2A1

3.40e-0497323CID004469987
Drug17alpha-estradiol

CKB BOC UGT2B15 UGT2B17 GUCY1B2 UGT2A3 LGALS4 UGT2A1

3.45e-041303328CID000000450
DrugAC1L1OBF

UGT2B15 UGT2B17

3.58e-0420322CID000032736
Drugpivalate

BOC PLXNA2

3.58e-0420322CID000006417
DrugUDP-glucose

UGT2B15 UGT2B17 UGT2A3 UGT2A1

3.83e-04247324CID000001166
DrugAsbestos, Serpentine

CKB TINAGL1 ASRGL1 NFATC2 MAPT

3.86e-04451325ctd:D017632
Drugo,p'-DDT

SPHK2 ASRGL1 HIVEP1 KCNA3 LIPG

3.86e-04451325ctd:C016340
Drugphenolate

UGT2B15 UGT2B17 UGT2A3 UGT2A1

4.25e-04254324CID000000996
DrugAC1L7AJI

UGT2B15 UGT2B17 UGT2A3 UGT2A1

4.38e-04256324CID000003750
Drugchrysin

UGT2B15 UGT2B17 UGT2A1

4.41e-04106323CID005281607
Drugfluconazole

UGT2B15 UGT2B17 UGT2A1

4.53e-04107323CID000003365
Drug2-acetylaminofluorene

UGT2B15 UGT2B17 UGT2A3 UGT2A1

4.78e-04262324CID000005897
Drug2-naphthylamine

UGT2B15 UGT2B17 UGT2A1

4.91e-04110323CID000007057
DiseaseAbnormality of the sense of smell, COVID-19 symptoms measurement, ageusia

UGT2A2 UGT2A1

1.14e-062322EFO_0600019, EFO_1001758, HP_0004408
Diseasecholic acid glucuronide measurement

UGT2B15 UGT2B17

3.42e-063322EFO_0800574
DiseaseX-25937 measurement

UGT2B15 UGT2B17

6.83e-064322EFO_0800937
Diseaseomega-3 polyunsaturated fatty acid measurement

UGT2B15 UGT2B17 MAPT LIPG

8.01e-06118324EFO_0010119
DiseaseX-24574 measurement

UGT2B15 UGT2B17

2.38e-057322EFO_0800897
Diseasedeoxycholic acid glucuronide measurement

UGT2B15 UGT2B17

3.18e-058322EFO_0800575
Disease4-androsten-3alpha,17alpha-diol monosulfate (3) measurement

UGT2B15 UGT2B17

5.10e-0510322EFO_0022090
DiseaseDNA repair protein RAD51 homolog 4 measurement

UGT2B15 UGT2B17

6.23e-0511322EFO_0801531
Disease5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement

UGT2B15 UGT2B17

7.47e-0512322EFO_0800291
Diseaseandrostenediol (3alpha, 17alpha) monosulfate (3) measurement

UGT2B15 UGT2B17

8.82e-0513322EFO_0800293
DiseaseX-19141 measurement

UGT2B15 UGT2B17

8.82e-0513322EFO_0800799
Disease5alpha-androstan-3alpha,17alpha-diol monosulfate measurement

UGT2B15 UGT2B17

1.03e-0414322EFO_0800283
Disease5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement

UGT2B15 UGT2B17

1.72e-0418322EFO_0800288
Diseaseetiocholanolone glucuronide measurement

UGT2B15 UGT2B17

1.93e-0419322EFO_0800362
Diseaseandrosterone glucuronide measurement

UGT2B15 UGT2B17

2.14e-0420322EFO_0800317
DiseaseX-24947 measurement

UGT2B15 UGT2B17

2.60e-0422322EFO_0800910
Diseaseepiandrosterone sulfate measurement

UGT2B15 UGT2B17

3.37e-0425322EFO_0021120
Diseasedocosahexaenoic acid measurement

UGT2B15 UGT2B17 LIPG

3.53e-04127323EFO_0007761
Diseaseandrosterone sulfate measurement

UGT2B15 UGT2B17

5.89e-0433322EFO_0021117
Diseasemalignant epithelial tumor of ovary

UGT2A2 UGT2A1

6.63e-0435322MONDO_0018364
Diseaseepilepsy (implicated_via_orthology)

KCNA3 KCNK17 MAPT

7.30e-04163323DOID:1826 (implicated_via_orthology)
Diseasehigh density lipoprotein particle size measurement

UGT2B15 UGT2B17 LIPG

8.24e-04170323EFO_0008592
DiseaseMemory Disorders

SPHK2 MAPT

1.00e-0343322C0025261
DiseaseMemory Loss

SPHK2 MAPT

1.00e-0343322C0751295
DiseaseAge-Related Memory Disorders

SPHK2 MAPT

1.00e-0343322C0751292
DiseaseMemory Disorder, Spatial

SPHK2 MAPT

1.00e-0343322C0751294
DiseaseMemory Disorder, Semantic

SPHK2 MAPT

1.00e-0343322C0751293
DiseaseMemory impairment

SPHK2 MAPT

1.05e-0344322C0233794
DiseaseQRS amplitude, QRS complex

HIVEP1 MAPT

1.35e-0350322EFO_0005054, EFO_0007742
Diseaseomega-6:omega-3 polyunsaturated fatty acid ratio

UGT2B15 UGT2B17

1.35e-0350322EFO_0010732
DiseaseAlzheimer's disease (implicated_via_orthology)

HIVEP1 MAPT

1.75e-0357322DOID:10652 (implicated_via_orthology)
Diseasetestosterone measurement

UGT2A2 UGT2B15 UGT2B17 MAPT CDC37L1 UGT2A1

2.22e-031275326EFO_0004908
Diseasecholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement

UGT2B15 UGT2B17 LIPG

2.29e-03243323EFO_0004612, EFO_0020944
Diseasecortical surface area measurement

TINAGL1 PKHD1 MAPT PLXNA2 GATAD2B EDEM2

2.90e-031345326EFO_0010736
Diseasemetabolite measurement

TINAGL1 UGT2B15 UGT2B17 ASRGL1

3.03e-03560324EFO_0004725
Diseasecholesterol:total lipids ratio, high density lipoprotein cholesterol measurement

UGT2B15 UGT2B17 LIPG

3.29e-03276323EFO_0004612, EFO_0020943
Diseasemigraine disorder, Headache

KCNK17 MAPT

3.93e-0386322HP_0002315, MONDO_0005277
Diseasephysical activity

PKHD1 LIPG

4.12e-0388322EFO_0003940

Protein segments in the cluster

PeptideGeneStartEntry
MNPIVVVHGGGAGPI

ASRGL1

1

Q7L266
QLYGGPVVLVAHSMG

PLA2G15

186

Q8NCC3
TYPHGVVPLSMGQLG

QRICH2

241

Q9H0J4
QPIPGGLNVGMSVYI

LGALS4

21

P56470
PTGGHPVVQLHGYME

NFATC2

436

Q13469
GLMPGYQGHVPTVAF

FAM166C

21

A6NJV1
VIQTGVDNPGHPYIM

CKB

56

P12277
VDNPGHPYIMTVGCV

CKB

61

P12277
VVMYHQPSAPAGIGG

LAYN

151

Q6UX15
KAGDMVYIVGHVPPG

SMPDL3B

226

Q92485
MPYGTVNLLHGVNPG

EDEM2

171

Q9BV94
DGPPHGGVQYEMVSV

PLXNA2

461

O75051
GCYPEGPMGIIQHLE

KCNK17

306

Q96T54
GYGDMHPVTIGGKIV

KCNA3

446

P22001
GIQMPVGHIDIYPNG

LIPG

231

Q9Y5X9
VPGGLLGMPGVNIAY

GATAD2B

541

Q8WXI9
PQHPVGAYVGQEPGM

BOC

1081

Q9BWV1
AGVVRNHGGYVDVMP

CRISPLD1

451

Q9H336
PPGQYATRMTGQVHG

LINC00526

26

Q96FQ7
PQLPGGGAQMYSHGI

CDC37L1

36

Q7L3B6
VQGVVVPMVHNGYGF

CROT

551

Q9UKG9
PIQGCMHGGRIYPVL

TINAGL1

101

Q9GZM7
AYMVVGGVPVPIGNH

GUCY1B2

441

O75343
MNGIHIDPGTIGVYG

PKHD1

2841

P08F94
VEYGPLQAQMHPGIG

SPHK2

626

Q9NRA0
HVPGGGSVQIVYKPV

MAPT

616

P10636
AIYHGVPMVGVPIFG

UGT2A3

381

Q6UWM9
YHGIPMVGIPLFADQ

UGT2B15

386

P54855
AGEQFIPGGPHLMLY

TMEM45A

66

Q9NWC5
AIYHGVPMVGVPMFA

UGT2A1

381

P0DTE4
YNMVPVGGIHVVPAG

HIVEP1

2396

P15822
YHGIPMVGIPLFADQ

UGT2B17

386

O75795
IYHGVPMVGVPMFAD

UGT2A2

391

P0DTE5
PLPQYVTVKGGHMIA

YEATS2

611

Q9ULM3